Advisors
- Dr. Jorge L. Castillo
- Dr. Martin Ferguson
- Dr. Paul Krasner
- Dr. Joseph Laning
- Dr. Nicholas Perrotta
- Dr. Paul T. Sharpe
Dr. Jorge L. Castillo
Dr. Castillo is a Diplomate of the American Board of Pediatric Dentistry.He is the Past-President of the Peruvian Society of Pediatric Dentistry and President of the Peruvian Society of Orthodontics.
He is a member of multiple local and international dental associations. Dr. Castillo is a member of the Editorial Board of several indexed international journals.
He is professor of the Department of Dentistry for Children and Adolescents at the Universidad Peruana Cayetano Heredia and Affiliate Assistant Professor of the Department of Public Health Sciences at the University of Washington.
He has authored several articles published in indexed journals and has lectured in Peru and other countries. Back to Top ⇧
Dr. Martin Ferguson
Dr. Ferguson is a consultant to pharmaceutical and life science informatics companies, and federal agencies engaged in or supporting translational biomedical research.He focuses on implementing complete ethical, legal, technical, clinical and informatics solutions for human subjects research involving clinically annotated biospecimens.
Prior, he was a founder of Ardais Corporation and co-developed the bioethical and legal frameworks under which the company worked with academic medical centers to bank "human subjects" data and biospecimens that were then distributed to industry and academic researchers.
Dr. Ferguson received his Ph.D. in Molecular Biophysics and Biochemistry from Yale University. Back to Top ⇧
Dr. Paul Krasner
Dr. Paul Krasner, clinical professor of endodontics at Temple University School of Dentistry, received his D.D.S. from Temple University in 1971 and a Certificate in Endodontology from Kingsbrook Jewish Medical Center (New York) in 1975. He completed general practice residencies at Berkshire Medical Center in 1972 and Queens General Hospital/Long Island Jewish Hospital in 1973. Dr. Krasner has been a faculty member of the department since 1977 and is a Diplomate of the American Board of Endodontics. He has a private practice in Pottstown, Pennsylvania. Back to Top ⇧Dr. Joseph Laning, PhD

Dr. Joseph Laning is an experienced executive, manager and scientist with over 16 years' experience in the fields of wound care, regenerative medicine, and cell therapy.
He began his career at Organogenesis, Inc. where he developed and implemented pre-clinical investigations and subsequently managed all patient immunology safety testing leading to the PMA approval of Apligraf™.
In 2002, he joined ViaCell, Inc. where he served as Director of Therapeutic Development and subsequently Senior Director of Analytical Biology. In these roles he oversaw strategic and operational scientific plans leading to successful approval of both IND and IDE FDA filings and completion of the company’s cell therapy clinical trial.
As part of these efforts Dr. Laning managed numerous scientific joint ventures with Amgen, J&J, and Alnylam investigating combinatorial stem cell product development initiatives in cardiac repair and hematopoietic reconstitution. He subsequently brought his extensive experience in scientific management and product development to scientific and business consulting opportunities in industry and academics as Founder and Principal of JCLaning Bio-Consulting.
Most recently he joined the Massachusetts Human Stem Cell Bank and Registry as Executive Director eager to complete the important tasks required to develop the Bank & Registry into the world class resource envisioned at its inception. He received his BA in Biology from Boston University and his PhD in Immunology from Harvard University. Back to Top ⇧
He began his career at Organogenesis, Inc. where he developed and implemented pre-clinical investigations and subsequently managed all patient immunology safety testing leading to the PMA approval of Apligraf™.
In 2002, he joined ViaCell, Inc. where he served as Director of Therapeutic Development and subsequently Senior Director of Analytical Biology. In these roles he oversaw strategic and operational scientific plans leading to successful approval of both IND and IDE FDA filings and completion of the company’s cell therapy clinical trial.
As part of these efforts Dr. Laning managed numerous scientific joint ventures with Amgen, J&J, and Alnylam investigating combinatorial stem cell product development initiatives in cardiac repair and hematopoietic reconstitution. He subsequently brought his extensive experience in scientific management and product development to scientific and business consulting opportunities in industry and academics as Founder and Principal of JCLaning Bio-Consulting.
Most recently he joined the Massachusetts Human Stem Cell Bank and Registry as Executive Director eager to complete the important tasks required to develop the Bank & Registry into the world class resource envisioned at its inception. He received his BA in Biology from Boston University and his PhD in Immunology from Harvard University. Back to Top ⇧
Dr. Nicholas Perrotta, DMD
General Dentistry
Dr. Nicholas Perrotta graduated from Tufts University School of Dental Medicine and received his DMD in 1988 and received his residency training at Albert Einstein Medical Center in New York.
Dr. Perrotta was a clinical retorative instructor at Tufts University School of Dental Medicine.
He currently owns a private practice since 1990 in Medord, Ma and sits on many executive dental boards, including his role as President of the East Middlesex District Dental Society.
Dr.Perrotta is a member of American Dental Society, Massachusetts Dental Society, East Middlesex District Dental Society and the American Dental Implant Association and been involved with stem cell technology since 2005. Back to Top ⇧
Dr. Perrotta was a clinical retorative instructor at Tufts University School of Dental Medicine.
He currently owns a private practice since 1990 in Medord, Ma and sits on many executive dental boards, including his role as President of the East Middlesex District Dental Society.
Dr.Perrotta is a member of American Dental Society, Massachusetts Dental Society, East Middlesex District Dental Society and the American Dental Implant Association and been involved with stem cell technology since 2005. Back to Top ⇧
Dr. Paul T. Sharpe
Paul T. Sharpe is the Dickinson Professor of craniofacial biology and the Director of Research at the Dental Institute, King's College London, London, UK.He graduated with a degree in biology from York University (1977) and a Ph.D. degree in biochemistry from Sheffield University, UK (1981).
He has published in excess of 200 research papers and supervised over 30 Ph.D. students.
Dr. Sharpe is the founder of Odontis, a company developing a biological replacement tooth product.
In 2006, Dr. Sharpe's paper "Stem cell-based tissue engineering of teeth" received the William J. Gies Award for best publication in biomaterials and bioengineering from the same organization. Back to Top ⇧











